Back to medications
Medication monograph

inotuzumab ozogamicin

Antibody-Drug ConjugatesMonoclonal AntibodiesAntineoplastic AgentsCD22-directed Immunoconjugate

Clinical reference

Product monograph

BESPONSA- inotuzumab ozogamicin injection, powder, lyophilized, for solution

Brands & formulations

Family members

BESPONSA

Marketed
0.9 MGINTRAVENOUSPOWDER FOR SOLUTION[ "inotuzumab ozogamicin" ]
Product monograph

Classification

Chemical class
Antibody-Drug Conjugates
Clinical class
Monoclonal Antibodies, Antineoplastic Agents
Banks class
CD22-directed Immunoconjugate